7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology

第七届动脉硬化、血栓形成和血管生物学年会

基本信息

项目摘要

The annual Spring meeting of the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Council of the American Heart Association is held together with the Nutrition, Physical Activity, and Metabolism (NPAM) Council of AHA. The meeting is intended to bring together junior and senior scientists working on basic and clinical aspects of cardiovascular disease for the purpose of advancing scientific interchange in order to facilitate a more rapid assimilation of new knowledge. By encompassing the many disciplines covered by the ATVB and NPAM councils, the meeting has a broader appeal that potentially provides interchanges and insights that would not otherwise become available. The design of the meeting is planned to encourage interaction and discussion and a key component of this meeting is educational. The size of the meeting is small enough to permit students and fellows to actively participate in poster and oral sessions together with well known national and international scientists from several disciplines. Overall, the specific aims of the conference are 1) to promote the exchange of scientific information and experimental strategies among investigators working in diverse areas pertinent to cardiovascular disease; 2) to identify and disseminate information about novel technologies that can advance research across all areas; 3) enhance the transfer of basic science findings into translational/preclinical studies and ultimately to clinical applications; 4) provide a forum for students and fellows to present data to a discriminating audience with an eye toward encouraging their development and retention in the field; and 5) to encourage investigators in related fields to become acquainted and to promote scientific collaborations among them. This meeting has been held annually since the year 2000, with attendance reaching about 800 participants including about 500 individual presentations. The trend for the size to remain constant and even increase with time is taken as a sign that continued success of the meeting is assured.
动脉硬化,血栓形成和血管生物学(ATVB)的年度春季会议(ATVB)理事会 美国心脏协会与营养,体育锻炼和新陈代谢(NPAM)共同举办 AHA委员会。这次会议旨在使初级和高级科学家聚集于基本和 心血管疾病的临床方面,目的是推进科学交换 促进新知识更快地同化。通过涵盖许多涵盖的学科 ATVB和NPAM委员会,会议具有更广泛的上诉,有可能提供交换和 否则将无法获得的见解。计划会议的设计鼓励 互动和讨论以及这次会议的关键组成部分是教育意义的。会议的大小是 足够小,可以让学生和研究员与 来自几个学科的国家和国际科学家。总体而言, 会议是1)促进科学信息和实验策略的交流 在不同地区工作的研究人员与心血管疾病有关; 2)识别和传播 有关可以推进各个领域研究的新型技术的信息; 3)增强转移 基础科学发现,转化/临床前研究,最终用于临床应用; 4)提供 为学生和研究员论坛,向歧视观众提供数据,以鼓励他们 他们在该领域的发展和保留; 5)鼓励相关领域的调查人员成为 熟悉并促进其中的科学合作。从那以后每年举行一次会议 2000年,出席人数大约有800名参与者,其中包括大约500个个人演讲。 尺寸保持恒定甚至随时间增加的趋势被视为持续的标志 会议的成功得到了保证。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lawrence L Rudel其他文献

Study of PRD125, a SOAT2-Selective Inhibitor, in Atherogenic Mouse Model.
PRD125(一种 SOAT2 选择性抑制剂)在致动脉粥样硬化小鼠模型中的研究。
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ohshiro T,Sawyer J;Matthew A Davis;Ohtawa M;Nagamitsu T;Lawrence L Rudel;Tomoda H.
  • 通讯作者:
    Tomoda H.

Lawrence L Rudel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lawrence L Rudel', 18)}}的其他基金

Administrative and Biostatistics Core
行政和生物统计核心
  • 批准号:
    7537466
  • 财政年份:
    2008
  • 资助金额:
    $ 1.5万
  • 项目类别:
ACAT2-Derived LDL Cholesteryl Esters In Atherosclerosis
ACAT2 衍生的 LDL 胆固醇酯在动脉粥样硬化中的作用
  • 批准号:
    7537452
  • 财政年份:
    2008
  • 资助金额:
    $ 1.5万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7114215
  • 财政年份:
    2006
  • 资助金额:
    $ 1.5万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7184324
  • 财政年份:
    2006
  • 资助金额:
    $ 1.5万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7768434
  • 财政年份:
    2006
  • 资助金额:
    $ 1.5万
  • 项目类别:
7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology
第七届动脉硬化、血栓形成和血管生物学年会
  • 批准号:
    7369693
  • 财政年份:
    2006
  • 资助金额:
    $ 1.5万
  • 项目类别:
Project 1- Mechanisms of Atherosclerosis Prevention
项目1-动脉粥样硬化预防机制
  • 批准号:
    6946076
  • 财政年份:
    2005
  • 资助金额:
    $ 1.5万
  • 项目类别:
Lipid Core
脂质核心
  • 批准号:
    6946093
  • 财政年份:
    2005
  • 资助金额:
    $ 1.5万
  • 项目类别:
LDL Cholesteryl Ester Metabolism in Atherosclerosis
动脉粥样硬化中的 LDL 胆固醇酯代谢
  • 批准号:
    7000684
  • 财政年份:
    2004
  • 资助金额:
    $ 1.5万
  • 项目类别:
2003 Kern Aspen Lipid Conference: Integrative Mechanisms
2003 年 Kern Aspen 脂质会议:综合机制
  • 批准号:
    6677630
  • 财政年份:
    2003
  • 资助金额:
    $ 1.5万
  • 项目类别:

相似海外基金

BLRD Merit Review Research Career Scientist (RCS) Award (IK6)
BLRD 优异评审研究职业科学家 (RCS) 奖 (IK6)
  • 批准号:
    10373035
  • 财政年份:
    2021
  • 资助金额:
    $ 1.5万
  • 项目类别:
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)
BLRD 优异评审研究职业科学家 (RCS) 奖 (IK6)
  • 批准号:
    10221206
  • 财政年份:
    2021
  • 资助金额:
    $ 1.5万
  • 项目类别:
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)
BLRD 优异评审研究职业科学家 (RCS) 奖 (IK6)
  • 批准号:
    10618157
  • 财政年份:
    2021
  • 资助金额:
    $ 1.5万
  • 项目类别:
BLR&D Merit Review Research Career Scientist Award Application
BLR
  • 批准号:
    10618233
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
BLR&D Merit Review Research Career Scientist Award Application
BLR
  • 批准号:
    10454104
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了